Malignancies in Patients with Inflammatory Bowel Disease: A Single-Centre Experience

Conclusion: Our data support the assumption that a long-standing disease course and immunosuppressive therapy increase the risk for developing malignancies in IBD patients.Digestion 2016;94:1-8

Source: Digestion - June 17, 2016 Category: Gastroenterology Source Type: research